Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Research and development

Litigation settlement gain

Restructuring and other charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Align Technology

Align Technology, Inc. engages in the design, manufacture, and market of orthodontics, restorative, and aesthetic dentistry products. It operates through the Clear Aligner, and Scanner and Services segments. The Clear Aligner segment consists of Invisalign full, teen, and assist products, and Vivera retainers for treating malocclusion. The Scanner and Services segment consists of intraoral scanning systems such as single hardware platforms and restorative or orthodontic software options, ancillary products, and other related additional services. The company was founded by Zia Chishti, Brian Freyburger, and Kelsey Wirth in March 1997 and is headquartered in Tempe, AZ.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Align Technology reports Q4 growth, eyes tech advancements for 2023

Align Technology's Q4 performance showed revenue growth in Systems and Services but challenges in Clear Aligner volumes, particularly in China.
The company is focusing on technology advancements, digital subscriptions, and margin improvement for 2023.
Investments in R&D for digital orthodontics and subscription programs present opportunities for future growth.
Despite challenges in China, Align remains optimistic about stability and growth in other regions.

Align Technology beats Q1 revenue expectations, eyes Q2 growth

Align Technology's Q1 performance exceeded expectations with revenue growth.
Stable Clear Aligner business and focus on teen market are strengths.
Challenges include increased expenses and uncertainty in margins.
Opportunities lie in expected volume and ASP increases in Q2.

Align Technology surpasses Q2 expectations, eyes international growth opportunities

Align Technology delivered strong Q2 results, driven by revenue growth in Clear Aligner and Systems and Services segments, with a focus on innovation and strategic initiatives.
The company's performance in international markets, particularly EMEA and APAC, showcased significant growth in teen cases and adoption of the DSP program.
While facing challenges in the teen market and competitive landscape, Align Technology remains optimistic about its long-term growth prospects and market positioning.
Opportunities for Align include continued innovation, market expansion, and investor engagement through strategic initiatives and product differentiation.

Align Technology reports Q3 revenue growth amidst macro challenges

Align Technology navigated challenges in Q3 with revenue growth driven by clear aligner shipments to younger patients and increased services revenue.
Despite lower Q3 demand, the company remains optimistic for 2024 revenue growth through new technologies and digital orthodontics adoption.
Strategic investments in R&D, cost management, and consumer advertising position Align Technology for future growth and margin improvement.

Align Technology surpasses Q4 expectations, eyes innovation for growth

Align Technology delivered strong financial performance in Q4 2023, with robust revenue growth and effective cost management.
The company's focus on innovation, strategic partnerships, and market expansion positions it well for future growth.
While facing challenges such as regulatory approvals and cash flow fluctuations, Align Technology has opportunities in market expansion and cost-saving initiatives.
Overall, Align Technology's performance, strengths, and strategic outlook indicate a positive trajectory for sustainable growth and profitability.

Align Technology posts solid Q1 earnings, eyes growth opportunities

Align Technology's Q1 performance reflects revenue growth and strategic investments in innovation and market expansion.
While facing challenges in operating expenses and margin decline, the company's strengths lie in product innovation and brand visibility.
Opportunities in new market expansion, targeting younger patients, and operational investments set the stage for future growth and profitability.

Align Technology posts solid Q2 results, eyes market expansion

Align Technology delivered strong financial performance in Q2, driven by revenue growth, margin expansion, and increasing adoption of its innovative solutions.
The company's focus on product innovation, digital tools, and marketing initiatives has bolstered its market position and customer engagement.
While facing challenges in a competitive landscape and regulatory processes, Align Technology remains well-positioned to capitalize on opportunities in the orthodontic market.
Strategic initiatives to drive growth, enhance operational efficiency, and expand market reach are key priorities for sustaining momentum and profitability.

Align Technology reports mixed Q3 results, eyes international growth

Align Technology's Q3 '24 showcased mixed results but highlighted growth opportunities in international markets and new product innovations.
Despite challenges in the U.S. market, the company's strategic focus on operational efficiency and digital innovation positions it for future success.
Investments in expansion and supporting doctor customers signal a commitment to driving growth and profitability in the long term.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Bath and Body Works

Carnival

Ceridian HCM Holding Inc.

Caesars Entertainment

EPAM Systems

Etsy

Netflix

PayPal

Royal Caribbean Cruises

Concerns about high inflation, aggressive rate hikes by the Federal Reserve, and the potential for an economic recession jolted investor sentiment.

These were the 10 worst performing stocks in the S&P 500 in its worst half since 1970

These stocks are down by 60% or more this year -- but are they long-term buys?

Should You Buy the S&P 500's 5 Worst-Performing 2022 Stocks?

These stocks have taken a beating this year but their growth potential remains promising.

2 of the Best Nasdaq Stocks to Buy for July

Align Technology's (ALGN) focus on expanding its global operations, both in existing and emerging international markets, raises optimism.

Align (ALGN) Gains From Increased Case Shipment Amid FX Woes

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry today announced a $250 thousand donation to JA (Junior Achievement) Worldwide through the Align Foundation, the Company's donor-advised charitable fund through Fidelity Charitable. The donation

Align™ Technology Celebrates Its 25th Anniversary With US$250,000 Contribution to JA Worldwide Through the Align Foundation to Support Both Organizations' Shared Purpose of Inspiring and Preparing Young People to Succeed

Align (ALGN) competes with products similar to Invisalign Technology, such as the products from Ormco Orthodontics, a division of Sybron Dental Specialties.

Align (ALGN) Hurt by Dental Practice Closures, FX Headwind

Recently, Align Technology Inc. ( ALGN , Financial) looked like a shooting star, with a stock price that soared from about $137 on March 23, 2020 to just over $729 on Sept. 2, 2021. That's a 5.32-fold increase in18 months.

Has Align Technology Reverted to the Mean?

Finding stocks that combine quality, growth and value into one package is challenging, but orthodontic device stock ALGN fits the bill. The post One High-Quality Stock You Need to Buy Right Now appeared first on InvestorPlace.

One High-Quality Stock You Need to Buy Right Now

Adobe

ASML Hld

Malibu Boats

5 High-Quality Stocks Sizzling this Summer

Align Technology, Inc. (NASDAQ:ALGN) is a dental care company that designs, manufactures, and sells the Invisalign clear aligners used in orthodontics, the iTero intraoral scanners, and the exocad CAD/CAM software.

Is Align Stock Truly Worth its High Valuation Today?

Henry Schein

Rising diabetes cases could lead to increased demand for oral hygiene.

This Is a Growth Opportunity You Probably Haven't Considered

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced the award of eleven research grants to universities under the company's twelfth Annual Research Award Program. “As evidenced by the number of first-time applicants, more and m

Align™ Technology Awards Funding to Universities Worldwide for Advancing Orthodontic and Dental Research

Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock?

Align Technology (ALGN) Down 9.8% Since Last Earnings Report: Can It Rebound?

DENTSPLY SIRONA

Global dental products provider Dentsply (NASDAQ: XRAY) stock has been plunging worse than the benchmark indices down (-34%) on the year.

Dentsply Stock is Repricing Itself

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at an upcoming financial conference. The presentation, as noted below, will be webcast live via the Investor Relations section of Align Tech

Align Technology to Speak at an Upcoming Financial Conference

Align Technology's (ALGN) new partnership will give doctors access to an alternative that helps reduce manual processes and creates a clear view of Invisalign treatment workflows.

Align Technology (ALGN) to Offer Asana Smiles With New Pact

Asana

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced an agreement with Asana, Inc. (NYSE: ASAN) (LTSE: ASAN), a leading work management platform for teams. The strategic partnership will offer Invisalign trained doctors in the U.S.

Align Technology and Asana Announce Strategic Partnership to Offer Asana Smiles™ for Align, a New Work Management Solution to Invisalign Trained Doctors in the United States

The next-generation of Align Technology's (ALGN) advanced patient communication tool will help patients see their potential new smile after Invisalign treatment.

Align Technology (ALGN) Debuts Invisalign Outcome Simulator Pro

TEMPE, Ariz. & MIAMI & COPENHAGEN, Denmark & LONDON--(BUSINESS WIRE)--Align Technology, Inc. (“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today introduced Invisalign Outcome Simulator Pro, the next generation of its advanced patient communication tool. This enables doctors to show patients th

Align Technology Introduces Invisalign Outcome Simulator Pro, Next Generation Patient Communication Tool Featuring In-Face Visualization of a Patient's Potential Future Smile in Minutes

Disney

For rational long-term investors, now could be the time to buy.

Are Investors Repeating Mistakes They Made in 2020?

Global growth slowdown has slashed EPS another 19% this year, but keep this dental innovator on your radar

Bear of the Day: Align Technology (ALGN)

Novocure

Their long-term prospects look great -- even if their current stock charts don't.

Nasdaq Bear Market: 3 Great Stocks to Buy That Are Down 50% or More

Becton, Dickinson and Co.

Cardinal Health

McKesson

Patterson Companies

SmileDirectClub

Although Covid-19 allowed people the excuse to not see their dentist, the necessary return could benefit these dental stocks to buy. The post 7 Stock Picks to Play the Post-Pandemic Return of Dental Visits appeared first on InvestorPlace.

7 Stock Picks to Play the Post-Pandemic Return of Dental Visits

Shopify

Investors shouldn't let recent price activity discourage them from buying shares of these two businesses.

News for Align Technology Stock (ALGN)